These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 34785098)

  • 1. Landscapes and dynamic diversifications of B-cell receptor repertoires in COVID-19 patients.
    Xiang H; Zhao Y; Li X; Liu P; Wang L; Wang M; Tian L; Sun HX; Zhang W; Xu Z; Ye B; Yuan X; Wang P; Zhang N; Gong Y; Bian C; Wang Z; Yu L; Yan J; Meng F; Bai C; Wang X; Liu X; Gao K; Wu L; Liu L; Gu Y; Bi Y; Shi Y; Zhang S; Zhu C; Xu X; Wu G; Gao GF; Yang N; Liu WJ; Yang P
    Hum Immunol; 2022 Feb; 83(2):119-129. PubMed ID: 34785098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of B Cell Receptor Repertoires Reveals Key Signatures of the Systemic B Cell Response after SARS-CoV-2 Infection.
    Zhang Y; Yan Q; Luo K; He P; Hou R; Zhao X; Wang Q; Yi H; Liang H; Deng Y; Hu F; Li F; Liu X; Feng Y; Li P; Qu L; Chen Z; Pan-Hammarström Q; Feng L; Niu X; Chen L
    J Virol; 2022 Feb; 96(4):e0160021. PubMed ID: 34878902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline IGHV3-53-encoded RBD-targeting neutralizing antibodies are commonly present in the antibody repertoires of COVID-19 patients.
    Yan Q; He P; Huang X; Luo K; Zhang Y; Yi H; Wang Q; Li F; Hou R; Fan X; Li P; Liu X; Liang H; Deng Y; Chen Z; Chen Y; Mo X; Feng L; Xiong X; Li S; Han J; Qu L; Niu X; Chen L
    Emerg Microbes Infect; 2021 Dec; 10(1):1097-1111. PubMed ID: 33944697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep Sequencing of B Cell Receptor Repertoires From COVID-19 Patients Reveals Strong Convergent Immune Signatures.
    Galson JD; Schaetzle S; Bashford-Rogers RJM; Raybould MIJ; Kovaltsuk A; Kilpatrick GJ; Minter R; Finch DK; Dias J; James LK; Thomas G; Lee WJ; Betley J; Cavlan O; Leech A; Deane CM; Seoane J; Caldas C; Pennington DJ; Pfeffer P; Osbourn J
    Front Immunol; 2020; 11():605170. PubMed ID: 33384691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global characterization of B cell receptor repertoire in COVID-19 patients by single-cell V(D)J sequencing.
    Jin X; Zhou W; Luo M; Wang P; Xu Z; Ma K; Cao H; Xu C; Huang Y; Cheng R; Xiao L; Lin X; Pang F; Li Y; Nie H; Jiang Q
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34015809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of B cell repertoires and emergence of cross-reactive responses in patients with different severities of COVID-19.
    Montague Z; Lv H; Otwinowski J; DeWitt WS; Isacchini G; Yip GK; Ng WW; Tsang OT; Yuan M; Liu H; Wilson IA; Peiris JSM; Wu NC; Nourmohammad A; Mok CKP
    Cell Rep; 2021 May; 35(8):109173. PubMed ID: 33991510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 B cell receptor signatures in at-risk populations.
    Flyak AI
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33216735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.
    Varnaitė R; García M; Glans H; Maleki KT; Sandberg JT; Tynell J; Christ W; Lagerqvist N; Asgeirsson H; Ljunggren HG; Ahlén G; Frelin L; Sällberg M; Blom K; Klingström J; Gredmark-Russ S
    J Immunol; 2020 Nov; 205(9):2437-2446. PubMed ID: 32878912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cell receptor repertoire kinetics after SARS-CoV-2 infection and vaccination.
    Kotagiri P; Mescia F; Rae WM; Bergamaschi L; Tuong ZK; Turner L; Hunter K; Gerber PP; Hosmillo M; ; Hess C; Clatworthy MR; Goodfellow IG; Matheson NJ; McKinney EF; Wills MR; Gupta RK; Bradley JR; Bashford-Rogers RJM; Lyons PA; Smith KGC
    Cell Rep; 2022 Feb; 38(7):110393. PubMed ID: 35143756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of Antibody and Cellular Immune Responses in Coronavirus Disease 2019 Patients Over Nine Months After Infection.
    Yao L; Wang GL; Shen Y; Wang ZY; Zhan BD; Duan LJ; Lu B; Shi C; Gao YM; Peng HH; Wang GQ; Wang DM; Jiang MD; Cao GP; Ma MJ
    J Infect Dis; 2021 Aug; 224(4):586-594. PubMed ID: 33978754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of SARS-CoV-2 Specific and Neutralizing Antibodies over Seven Months after Symptom Onset in COVID-19 Patients.
    Zhu L; Xu X; Zhu B; Guo X; Xu K; Song C; Fu J; Yu H; Kong X; Peng J; Huang H; Zou X; Ding Y; Bao C; Zhu F; Hu Z; Wu M; Shen H
    Microbiol Spectr; 2021 Oct; 9(2):e0059021. PubMed ID: 34550000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal Profiling of Antibody Response in Patients With COVID-19 in a Tertiary Care Hospital in Beijing, China.
    Feng X; Yin J; Zhang J; Hu Y; Ouyang Y; Qiao S; Zhao H; Zhang T; Li X; Zhang L; Zhang J; Jin R; Feng Y; Su B
    Front Immunol; 2021; 12():614436. PubMed ID: 33790892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19.
    Woodruff MC; Ramonell RP; Nguyen DC; Cashman KS; Saini AS; Haddad NS; Ley AM; Kyu S; Howell JC; Ozturk T; Lee S; Suryadevara N; Case JB; Bugrovsky R; Chen W; Estrada J; Morrison-Porter A; Derrico A; Anam FA; Sharma M; Wu HM; Le SN; Jenks SA; Tipton CM; Staitieh B; Daiss JL; Ghosn E; Diamond MS; Carnahan RH; Crowe JE; Hu WT; Lee FE; Sanz I
    Nat Immunol; 2020 Dec; 21(12):1506-1516. PubMed ID: 33028979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects.
    Huynh A; Arnold DM; Smith JW; Moore JC; Zhang A; Chagla Z; Harvey BJ; Stacey HD; Ang JC; Clare R; Ivetic N; Chetty VT; Bowdish DME; Miller MS; Kelton JG; Nazy I
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33923828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of B-cell receptor clonality and immunoglobulin gene usage at multiple time points during active SARS-CoV-2 infection.
    Arons E; Henry K; Haas C; Gould M; Tsintolas J; Mauter J; Zhou H; Burbelo PD; Cohen JI; Kreitman RJ
    J Med Virol; 2023 Oct; 95(10):e29179. PubMed ID: 37877800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal Analysis of T and B Cell Receptor Repertoire Transcripts Reveal Dynamic Immune Response in COVID-19 Patients.
    Niu X; Li S; Li P; Pan W; Wang Q; Feng Y; Mo X; Yan Q; Ye X; Luo J; Qu L; Weber D; Byrne-Steele ML; Wang Z; Yu F; Li F; Myers RM; Lotze MT; Zhong N; Han J; Chen L
    Front Immunol; 2020; 11():582010. PubMed ID: 33117392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follicular Helper T Cells in the Immunopathogenesis of SARS-CoV-2 Infection.
    Cui D; Tang Y; Jiang Q; Jiang D; Zhang Y; Lv Y; Xu D; Wu J; Xie J; Wen C; Lu L
    Front Immunol; 2021; 12():731100. PubMed ID: 34603308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elicitation of Broadly Neutralizing Antibodies against B.1.1.7, B.1.351, and B.1.617.1 SARS-CoV-2 Variants by Three Prototype Strain-Derived Recombinant Protein Vaccines.
    Yang Y; Zang J; Xu S; Zhang X; Yuan S; Wang H; Lavillette D; Zhang C; Huang Z
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Landscape of B Cell Receptor Repertoires in COVID-19 Patients Revealed Through CDR3 Sequencing of Immunoglobulin Heavy and Light Chains.
    Gao H; Yu L; Yan F; Zheng Y; Huang H; Zhuang X; Zeng Y
    Immunol Invest; 2022 Oct; 51(7):1994-2008. PubMed ID: 35797435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2-specific antibody rearrangements in prepandemic immune repertoires of risk cohorts and patients with COVID-19.
    Paschold L; Simnica D; Willscher E; Vehreschild MJ; Dutzmann J; Sedding DG; Schultheiß C; Binder M
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33064671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.